Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Asset Utilization Ratio (2023 - 2026)

bioAffinity Technologies has reported Asset Utilization Ratio over the past 4 years, most recently at 0.6 for Q1 2026.

  • Quarterly Asset Utilization Ratio fell 59.01% to 0.6 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.6 through Mar 2026, down 59.01% year-over-year, with the annual reading at 0.71 for FY2025, 44.5% down from the prior year.
  • Asset Utilization Ratio was 0.6 for Q1 2026 at bioAffinity Technologies, up from 0.55 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 1.49 in Q2 2025 and troughed at 0.0 in Q1 2023.
  • The 4-year median for Asset Utilization Ratio is 0.61 (2024), against an average of 0.75.
  • Year-over-year, Asset Utilization Ratio soared 119993.65% in 2024 and then tumbled 61.79% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.28 in 2023, then skyrocketed by 420.91% to 1.43 in 2024, then tumbled by 61.79% to 0.55 in 2025, then grew by 9.35% to 0.6 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Asset Utilization Ratio are 0.6 (Q1 2026), 0.55 (Q4 2025), and 0.83 (Q3 2025).